Document Detail

Postextubation laryngeal edema in adults. Risk factor evaluation and prevention by hydrocortisone.
MedLine Citation:
PMID:  8905428     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To evaluate the risk factors for postextubation laryngeal stridor and its prevention by hydrocortisone in adult patients. DESIGN: Prospective, randomized, double-blind, placebo controlled study. SETTING: Medical and surgical ICU of a tertiary teaching hospital. PATIENTS: 77 consecutive patients of both sexes, who had undergone tracheal intubation for more than 24 h and fulfilled the weaning criteria, were eligible for the study. Patients were excluded if they were less than 15 years of age, had a disease or the surgery of the throat, or had been extubated during the current hospitalization. INTERVENTION: The control group received placebo (normal saline 3 cc) and the experimental group received hydrocortisone 100 mg by intravenous infusion 60 min before extubation. MAIN OUTCOME MEASURES: Patients were observed 24 h after extubation for symptoms or signs of laryngeal edema or stridor: prolonged inspiration with accessory usage of respiratory muscles or crowing sound with inspiration or reintubation. RESULTS: The overall incidence of postextubation stridor was 22% (17/77). Only one patient (1%), who belonged to the control group, needed reintubation. 39% of female patients and 17% of male patients developed stridor. The relative risk of females developing this complication was 2.29. 7/39 of the hydrocortisone group and 10/38 of patients in the control group developed postextubation stridor. CONCLUSIONS: Hydrocortisone did not significantly reduce the incidence of postextubation laryngeal edema or stridor. From the risk factors evaluated, we were unable to demonstrate a statistical correlation between postextubation stidor and the duration of the intubation, the patient's age, the internal diameter of the endotracheal tube, or the route of intubation. However, female patients were more likely to develop this complication.
L I Ho; H J Harn; T C Lien; P Y Hu; J H Wang
Related Documents :
21845058 - Symptom predictors of response to electroconvulsive therapy in older patients with trea...
17919698 - Evaluation of practice efficiency with a novel sheathed flexible cystoscope: a randomiz...
11092778 - Fear reduction in patients with dental treatment phobia.
22216038 - Post-traumatic stress disorder, depression, and heart-rate variability among north kore...
11256658 - Delirious mania.
11335698 - The multiple sclerosis impact scale (msis-29): a new patient-based outcome measure.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Intensive care medicine     Volume:  22     ISSN:  0342-4642     ISO Abbreviation:  Intensive Care Med     Publication Date:  1996 Sep 
Date Detail:
Created Date:  1997-02-18     Completed Date:  1997-02-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7704851     Medline TA:  Intensive Care Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  933-6     Citation Subset:  IM    
Department of Respiratory Therapy, Veterans General Hospital-Taipei, Taiwan, R.O.C.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Inflammatory Agents / therapeutic use*
Double-Blind Method
Hydrocortisone / therapeutic use*
Intubation, Intratracheal / adverse effects*
Laryngeal Edema / drug therapy*,  etiology*
Middle Aged
Prospective Studies
Respiratory Sounds / etiology
Risk Factors
Time Factors
Reg. No./Substance:
0/Anti-Inflammatory Agents; 50-23-7/Hydrocortisone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of positive end-expiratory pressure on right ventricular function in COPD patients during ac...
Next Document:  Percutaneous dilatational cricothyroidotomy: outcome with 44 consecutive patients.